LG Science Factive elected to be New Drug Development Award.

Published: 2004-02-10 06:59:00

Updated: 2004-02-10 06:59:00

"Factive" developed by LG Science was elected to the New Drug Development Award, assessing its value globally recognized as a new drug approved by the U.S. FDA for the first time in Korea.

The award ceremony was scheduled to take place at the Federation of Korea Industry Hall separately after ...

Fees

- Email service daily and homepage access.

$300 per month. ($3,240 per year)
5 Email holders per each company.
Anual contract base.

Latest News

Which are outstanding tetravalent vaccines even for the young?

Disease treated the most with clinical trial drugs is respiratory disorder like lung cancer

Who will be the next Pharmaceutical Safety Bureau Director?

Celltrion completes clinical trials for Remsima SC for European approval

Sales listed pharmas made in the first half of the year

TOP

BACK